524663 — Bharat Immunologicals and Biologicals Share Price
Last trade - 00:00- IN₹1.28bn
- IN₹1.95bn
- IN₹446.09m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.63 | ||
| Price to Tang. Book | 1.63 | ||
| Price to Free Cashflow | 11.77 | ||
| Price to Sales | 16.75 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -22.77% | ||
| Return on Equity | -21% | ||
| Operating Margin | -265.1% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 836.46 | 668.37 | 853.34 | 783.88 | 446.09 | n/a | n/a | 5.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bharat Immunologicals and Biologicals Corporation Limited is an India-based biotechnology company. The Company is primarily engaged in the manufacture of oral polio vaccine, zinc tablet, and diarrhea management kit. It operates under various segment, namely oral polio vaccine, zinc tablets, BIB VIT, and BIBSANIT. It is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The Company is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). It is also diversified into plasma-derived medicines and Oral Cholera vaccines. The Company's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.
Directors
- M. K. Bhan CHM
- Sreeshan Raghwan MDR
- Sandip Lal SEC
- N.K. Ganguly NID
- Y. Gupta NID
- B. Jailkhani NID
- Rajesh Kapur NID
- Rajesh Kumar NID
- Anuradha Mitra NID
- K. Sreenivasulu NID
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- March 10th, 1989
- Public Since
- August 4th, 1994
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 43,180,000
- Address
- OPV Plant, Village Chola, BULANDSHAHR, 203203
- Web
- https://www.bibcol.com/
- Phone
- +91 5732238758
- Auditors
- Rasool Singhal & Co.
Upcoming Events for 524663
Similar to 524663
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
As of Today at 19:04 UTC, shares in Bharat Immunologicals and Biologicals are trading at IN₹29.68. This share price information is delayed by 15 minutes.
Shares in Bharat Immunologicals and Biologicals last closed at IN₹29.68 and the price had moved by +19.73% over the past 365 days. In terms of relative price strength the Bharat Immunologicals and Biologicals share price has underperformed the S&P BSE 100 Index by -7.14% over the past year.
There is no consensus recommendation for this security.
Bharat Immunologicals and Biologicals does not currently pay a dividend.
Bharat Immunologicals and Biologicals does not currently pay a dividend.
Bharat Immunologicals and Biologicals does not currently pay a dividend.
To buy shares in Bharat Immunologicals and Biologicals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹29.68, shares in Bharat Immunologicals and Biologicals had a market capitalisation of IN₹1.28bn.
Here are the trading details for Bharat Immunologicals and Biologicals:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524663
Based on an overall assessment of its quality, value and momentum Bharat Immunologicals and Biologicals is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bharat Immunologicals and Biologicals. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +3.52%.
As of the last closing price of IN₹29.68, shares in Bharat Immunologicals and Biologicals were trading +7.38% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bharat Immunologicals and Biologicals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹29.68.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bharat Immunologicals and Biologicals' management team is headed by:
- M. K. Bhan - CHM
- Sreeshan Raghwan - MDR
- Sandip Lal - SEC
- N.K. Ganguly - NID
- Y. Gupta - NID
- B. Jailkhani - NID
- Rajesh Kapur - NID
- Rajesh Kumar - NID
- Anuradha Mitra - NID
- K. Sreenivasulu - NID